Navigation Links
Study Pinpoints Optimal Treatment Window for HIV
Date:1/16/2013

WEDNESDAY, Jan. 16 (HealthDay News) -- A new study shows the advantage of beginning antiretroviral therapy within four months of infection with HIV, the virus that causes AIDS.

Researchers analyzed data from nearly 500 patients infected with HIV-1 and found that those who began antiretroviral therapy within four months of their infection date -- and had higher CD4+ T-cell counts at the start of therapy -- had a stronger recovery of key CD4+ T-cell counts than those who began treatment later.

Normal CD4+ T-cell counts were restored in 64 percent of patients who began antiretroviral therapy within four months of infection, compared with 34 percent of patients who began treatment later.

CD4+ T-cells -- specialized immune cells that fight infections -- are depleted in people with HIV, the researchers said. In the four months after a person is infected with HIV, the immune system tries to boost levels of CD4+ T-cells. After this temporary increase, levels of the cells begin to decline, explained the authors of the study, which was published Jan. 17 in the New England Journal of Medicine.

"This study suggests greater urgency to start antiretroviral therapy earlier, when the most weapons in the immunity armamentarium are at the body's disposal," co-lead author Dr. Sunil Ahuja, a professor of medicine, microbiology/immunology and biochemistry in the School of Medicine at the University of Texas Health Science Center at San Antonio, said in a center news release.

Ahuja also is director of the Veterans Administration Center for AIDS and HIV Infection, a national center within the South Texas Veterans Health Care System.

Other experts agreed that the study points to the importance of early treatment.

"The question of when to begin [antiretroviral therapy] remains a difficult one," but this study and others provide strong supportive evidence suggesting a benefit for early therapy, Dr. Bruce Walker and Dr. Martin Hirsch, of Harvard Medical School, wrote in an accompanying journal editorial.

More information

AIDS.gov has more about CD4 cell count.

-- Robert Preidt

SOURCE: University of Texas Health Science Center at San Antonio, news release, Jan. 16, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Fetal Deaths Up Among Unvaccinated Moms in H1N1 Pandemic: Study
2. Smartphone Apps for Skin Cancer Risk Arent Reliable, Study Finds
3. As Parents Share of College Fees Rises, Students GPAs Fall: Study
4. Breast Cancer Message Board study finds frequent discussion of drug side effects, stopping therapy
5. U of T and Harvard study finds growing weight extremes in the developing world
6. Study examines link between incarceration and psychiatric disorders
7. Blood Clots During Pregnancy More Likely After IVF, Study Says
8. New SMU-North Texas food bank study to analyze causes of hunger in North Texas
9. Unneeded Antibiotics May Lead to Diarrheal Illness, Study Finds
10. Study Finds Low Flu Vaccine Rates in U.S. Kids
11. Kaiser Permanente study: Change in PSA levels over time can help predict aggressive prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Pinpoints Optimal Treatment Window for HIV
(Date:5/4/2016)... , ... May 04, 2016 , ... Level 10 Head ... her verbal commitment to the University of Arizona for the fall of 2019. ... decision last month. Brovedani’s commitment to the GymCats came from her connection with the ...
(Date:5/4/2016)... ... ... The Spiritual Care Association (SCA) has declared May 10, 2016 ... and their families, and their overall contribution to the health care system. It will ... sent “Thank You Chaplain” cards with hand-painted artwork to about 10,000 chaplains and pastoral ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star Insurance of ... assist the people of their local community. The agency pledges to select a ... Their hope is to bring awareness to important local causes with fundraising and ...
(Date:5/4/2016)... ... May 04, 2016 , ... Momsense, Inc. ... The company’s patented technology, The Smart Breastfeeding Meter, is designed to monitor and ... technology is now available for purchase at Target.com . , Breastfeeding ...
(Date:5/4/2016)... Plainsboro, NJ (PRWEB) , ... May 04, 2016 ... ... for pharmacists and the pharmacy industry, today announced that it was chosen as ... Purchasing Alliance (APPA) Industry Awards . The awards acknowledge the hard work and ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016  It,s time for an upgrade. There are many medical recorders ... 3.5 inch LCD, the illustrious DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix ... a world class manufacturer of innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... 2016 Valeritas Holdings, Inc. (OTCQB: ... public offering (APO). This was accomplished via a reverse ... and a private placement of approximately 5 million shares ... Under the terms of the reverse merger, ... Inc. will trade on the OTC Markets under the ...
(Date:5/4/2016)... Research and Markets has ... lymphocytic Leukemia Market and Competitive Landscape Highlights ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... and Competitive Landscape Highlights 2016, provides comprehensive ... Acute Lymphocytic Leukemia epidemiology, Acute Lymphocytic Leukemia ...
Breaking Medicine Technology: